23andMe Holding Co. (NASDAQ:ME) Q4 2023 Earnings Call Transcript

Operator: Hello, and welcome to 23andMe's Fiscal Year 2023 Fourth Quarter and Full Year Financial Results Conference Call. As a reminder, this call is being recorded.

Related Keywords

United States ,American ,Daniel Grosslight ,John Ward ,Kenneth Hillan ,Reza Afkhami ,Daniel Chu ,Joe Selsavage ,Noura Abul Husn ,Maeve Conneighton ,Steven Mah ,Anne Wojcicki ,David Baker ,American Association For Cancer Research ,Corporate Development ,Novartis ,Lemonaid Health ,Nasdaq ,Consumer Research ,Genomic Health ,Pfizer ,Me Holding Co ,Given The Company ,Genomic Health Services ,Consumer Research Services ,Mariner Energy Inc ,Corporate Development Officer ,Call Transcript May ,Fiscal Year ,Full Year Financial Results Conference ,Investor Relations ,Cargo Partners ,Forward Looking Statements ,Chief Executive Officer ,Interim Chief Financial ,Accounting Officer ,Chief Therapeutics Officer ,Chief Product Officer ,Vice President ,Chief Security Officer ,Chief Marketing Officer ,American Association ,Cancer Research ,Annual Meeting ,Chief Corporate Development Officer ,Senior Vice President ,Global Blood Therapeutics ,Research Services ,Chief Corporate Development ,